skinvision logo
Skin Health

Skin Health in depth

Want to know more about skin health?

Read the personal stories of SkinVision users. How they used SkinVision and how it affected their lives. Want to share your story with the world and make people more aware of the importance of skin health? Share your story and we will get it out there.

SkinVision Icon
Press Release

SkinVision partners with leading Australian sun protective clothing brand Solbari

SkinVision partners with leading Australian sun protective clothing brand Solbari to support the fight against Skin Cancer.

SkinVision Icon
News

SkinVision adopted by leading Australian health fund in the fight against skin cancer

As the world awakens to consider its new normal in the midst of the COVID-19 pandemic, digital technology is providing new hope in the fight against skin cancer, a disease that doesn’t respond to the idea of a pause. 

SkinVision Icon
Press Release

SkinVision and UV-Fashions team up to fight skin cancer

AMSTERDAM, 7 May 2020 – Spring and warm weather are here to stay for the coming months. Despite the fact that many aspects of our daily lives have changed drastically, responsible sun behaviour and timely detection of skin cancer remain more important than ever.

SkinVision Icon
Press Release

SkinVision Achieves Three ISO Certifications

SkinVision, the leading app for early detection of skin cancer, recently achieved three important ISO certifications. The British Standards Institution (BSI Group), awarded SkinVision ISO 13485:2016 for its quality management system. Additionally BSI awarded the company ISO 27001:2013 for information security management, as well as the Dutch national standard NEN 7510, which includes additional requirements […]

SkinVision Icon
Press Release

Milestone for SkinVision: Three Important Certifications Achieved

SkinVision, the leading app for early skin cancer detection, recently achieved three important ISO certifications. The British Standards Institution (BSI), awarded SkinVision ISO 13485:2016 for its quality management system. Additionally, BSI awarded the company ISO 27001:2013 for information security management, as well as the Dutch national standard NEN 7510:2017, which includes additional requirements to ISO 27001:2013, specifically for healthcare providers in the Netherlands, where SkinVision is based. 

SkinVision Icon
Press Release

New Study Finds SkinVision Detects 95% of Skin Cancer 

Amsterdam, 12 September 2019​ – An international group of researchers working with Erasmus University Medical Center (Erasmus MC) in the Netherlands determined that SkinVision – the first CE-marked skin cancer application based on extensive clinical trials – has a sensitivity of 95.1% in detecting the most common forms of skin cancer. 

SkinVision Icon
Press Release

SkinVision Joins the DigitalHealth.London Accelerator

Smartphone App for Skin Cancer Risk Selected to Join DigitalHealth.London Accelerator

SkinVision, a mobile application driving early skin cancer detection by empowering individuals to monitor their skin for early signs of skin cancer, has been selected to join the DigitalHealth.London Accelerator. 

SkinVision Icon
Press Release

Press Release: 3.6M CZ policyholders offered the SkinVision Service

Dutch Health Insurer CZ and SkinVision partner to create an impact in early skin cancer detection

SkinVision Icon
Press Release

Generali and SkinVision Offer New Service for Skin Cancer Screening in Germany

For about two decades, the number of skin cancers across Europe has been rising steadily.  Every year more than 200,000 people in Germany are diagnosed with the disease – and the trend is rising. The earlier skin cancer is detected, the higher the chances of patient survival. To counteract the rising numbers, SkinVision has partnered […]

SkinVision Icon
Press Release

Skin Cancer App SkinVision Raises $7.6 Million to Further Mission of Saving 250,000 Lives

AMSTERDAM, July 30 2018 — The SkinVision team is thrilled to announce the investment of $US7.6 million in the company to support their journey of bringing convenient, accurate and quick recognition of skin cancer. This funding round has been supported by current shareholders LEO Pharma, PHS Capital and a number of new high net worth impact investors.